REG - CT Healthcare Trust - Director/PDMR Shareholding

CT Healthcare TrustAnnouncement

26/03/2026 16:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260326:nRSZ3308Ya&default-theme=true

RNS Number : 3308Y  CT Healthcare Trust PLC  26 March 2026

CT HEALTHCARE TRUST plc

 

LEI: 213800HQ3J3H9YF2UI82

Director dealings

CT Healthcare Trust plc announces that the undermentioned director of the
Company sold and following settlement, repurchased Ordinary Shares through a
Bed and ISA arrangement, in order to affect the transfer of the Ordinary
Shares to their respective ISA account.

The transactions are summarised below:

  Director   Shares sold  Shares acquired  Total holding following notification
 Tony Young  2,843        2,823            37,491

The relevant notifications set out below are provided in accordance with the
requirements of UK Market Abuse Regulation.

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Tony Young

 2    Reason for the notification

 a)   Position/status                                              Director

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CT Healthcare Trust Plc

 b)   LEI

                                                                   213800HQ3J3H9YF2UI82

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Redeemable Ordinary Shares

      Identification code                                          ISIN  GB00BZCNLL95

 b)   Nature of the transaction                                    Sale of 2,843 shares and repurchase of 2,823 shares

 c)   Price(s) and volume(s)

                                                                                     Price(s)           Volume(s)
      Transaction 1 (sale)                                                           125.4p per share   2,843

                                                                                     125.4p per share

      Transaction 2 (purchase)                                                                          2,823

 d)   Aggregated information

      - Aggregated volume                                          Sale: 2,843

Purchase: 2,823

      - Price                                                      Total price sale: £3,565.12

Total price purchase: £3,540.04

 e)   Date of the transaction                                       25 March 2026

 f)   Place of the transaction                                     London Stock Exchange

b)

 

Nature of the transaction

 

 

Sale of 2,843 shares and repurchase of 2,823 shares

c)

 

Price(s) and volume(s)

 

Price(s)

Volume(s)

Transaction 1 (sale)

 

Transaction 2 (purchase)

 

125.4p per share

125.4p per share

2,843

 

2,823

d)

 

Aggregated information

- Aggregated volume

Sale: 2,843

Purchase: 2,823

- Price

Total price sale: £3,565.12

Total price purchase: £3,540.04

e)

 

Date of the transaction

 

 

 25 March 2026

f)

 

Place of the transaction

 

 

London Stock Exchange

 

Enquiries:

NSM Funds (UK) Limited

Bellevue@nsm.group

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHBLGDXSXDDGLL



            Copyright 2019 Regulatory News Service, all rights reserved